Park Ha Biological Tech Co. L
13F holders, Q2 2026 (June 30)4holders +1
2new positions
1sold out
$1.02avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Park Ha Biological Tech Co. L in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Virtu Financial LLC ($29K), Morgan Stanley ($25K) and Caitong International Asset Management Co., Ltd ($3).
- Company
- Park Ha Biological Tech Co. L
- CUSIP
- G6925R110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 1 | $84 |
All 13F filers, Q1 2026 → Q2 2026: 53,443 shares bought and 80 shares sold, net +53,363 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Virtu Financial LLC | 0.00% | New | 28,440 | $29K |
| Morgan Stanley | 0.00% | Add +156250.0% | 25,016 | $25K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 3 | $3 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PARK HA BIOLOGICAL TECH CO L's weight in each manager's 13F, not the share of Park Ha Biological Tech Co. L the manager owns.